Search Results 1671-1680 of 15589 for Orange Peel tea

1. Antiandrogen Therapy And Radiation Therapy With Or Without Docetaxel In Treating Patients With Prostate Cancer That Has Been Removed By Surgery - Mayo Clinic

   Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop ...

2. Venetoclax, Ixazomib Citrate, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   ... skin cancer or carcinoma in situ of any type are not excluded if they have undergone complete resection; Any of the following: Pregnant women; Nursing women ...

3. A Study Of ART24 In Subjects Recently Cured Of A Clostridioides Difficile Infection (CDI) - Mayo Clinic

   The purpose of this study is to evaluate the safety and tolerability of ART24 after 7 or 28 days of daily administration in recently-cured C. diff infection ...

4. Safety, Efficacy And Tolerability Of Ianalumab Versus Placebo, Combination With SoC Therapy, In Participants With Active Lupus Nephritis - Mayo Clinic

   ... skin or or in-situ cervical cancer), treated or untreated, within the past 5 years, regardless of whether there is evidence of local recurrence or metastases * ...

5. Trial Of Eflornithine Plus Sulindac In Patients With Familial Adenomatous Polyposis (FAP) - Mayo Clinic

   No invasive malignancy within the past 5 years except resected non-melanomatous skin cancer, papillary thyroid cancer, or precancerous cervical dysplasia.

6. Higher Per Daily Treatment-Dose Radiation Therapy Or Standard Per Daily Treatment Radiation Therapy In Treating Patients With Early-Stage Breast Cancer That Was Removed By Surgery - Mayo Clinic

   No prior invasive non-breast malignancy (except non-melanomatous skin cancer or carcinoma in situ of the cervix) unless disease free for a minimum of 5 years ...

7. Pembrolizumab, Lenalidomide, And Dexamethasone In Treating Patients With Newly Diagnosed Multiple Myeloma Eligible For Stem Cell Transplant - Mayo Clinic

   NOTE: Patients with nonmelanoma skin cancer or carcinoma in situ of any type are not excluded if they have undergone complete resection. Any of the following ...

8. CTX131 In Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Diagnosis with another invasive malignancy in the last 5 years with the exception of nonmelanoma skin cancer and malignancies deemed by the investigator and ...

9. Cyclophosphamide, Ixazomib, And Dexamethasone In Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

   Ixazomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving cyclophosphamide together with ixazomib and ...

10. A Study Of A Therapeutic DNA Vaccine For Chronic Hepatitis C Virus (HCV) Infection - Mayo Clinic

    Exception: non-melanoma skin cancer(s) for which diagnosis and treatment was completed ≥ 3 years prior to pre-registration. History of major organ ...